Werba Rubin Papier Wealth Management’s Gilead Sciences GILD Stock Holding History

Werba Rubin Papier Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	8,749 +212	+2%	+$27.9K	0.13%	88
2026 Q1	$1.19M	Buy	8,537 +328	+4%	+$45.9K	0.17%	72
2025 Q4	$1.01M	Buy	8,209 +267	+3%	+$32.4K	0.27%	62
2025 Q3	$882K	Sell	7,942 -14	-0.2%	-$1.59K	0.14%	81
2025 Q2	$882K	Buy	7,956 +80	+1%	+$8.51K	0.17%	81
2025 Q1	$883K	Sell	7,876 -40	-0.5%	-$4.13K	0.19%	74
2024 Q4	$731K	Sell	7,916 -6,179	-44%	-$556K	0.17%	77
2024 Q3	$1.18M	Buy	14,095 +367	+3%	+$28K	0.28%	54
2024 Q2	$942K	Buy	13,728 +242	+2%	+$16.1K	0.26%	58
2024 Q1	$988K	Buy	13,486 +23	+0.2%	+$1.77K	0.29%	47
2023 Q4	$1.09M	Sell	13,463 -52	-0.4%	-$4.05K	0.37%	31
2023 Q3	$1.01M	Buy	+13,515	New	+$1.04M	0.36%	35

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Werba Rubin Papier Wealth Management's GILD Position: Q2 2026 in Review

Werba Rubin Papier Wealth Management increased its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, buying an estimated $27.9K and bringing the position to 8,749 shares worth $1.11M. The position accounts for 0.13% of the portfolio, ranked #88.

Werba Rubin Papier Wealth Management first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.19M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Werba Rubin Papier Wealth Management held 8,749 shares of Gilead Sciences worth $1.11M as of Q2 2026.
Werba Rubin Papier Wealth Management bought 212 Gilead Sciences shares in Q2 2026, an estimated $27.9K.
Gilead Sciences made up 0.13% of Werba Rubin Papier Wealth Management's portfolio in Q2 2026, its #88 holding.
Werba Rubin Papier Wealth Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
Werba Rubin Papier Wealth Management's Gilead Sciences position peaked at $1.19M in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Werba Rubin Papier Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.